Cited by 587SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studiesvaccines and immunoinformatics approaches

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

Open access

Walls, Alexandra C., Xiong, Xiaoli, Park, Young-Jun, Tortorici, M. Alejandra, Snijder, Joost, Quispe, Joel, Cameroni, Elisabetta, Gopal, Robin, Dai, Mian, Lanzavecchia, Antonio, Zambon, Maria, Rey, Félix A., Corti, Davide, Veesler, David·2019·Cell

DOI 10.1016/j.cell.2018.12.028PMC PMC6751136

Open this paper in CoChat — free account Open PDF

Abstract

Recent outbreaks of severe acute respiratory syndrome and Middle East respiratory syndrome, along with the threat of a future coronavirus-mediated pandemic, underscore the importance of finding ways to combat these viruses. The trimeric spike transmembrane glycoprotein S mediates entry into host cells and is the major target of neutralizing antibodies. To understand the humoral immune response elicited upon natural infections with coronaviruses, we structurally characterized the SARS-CoV and MERS-CoV S glycoproteins in complex with neutralizing antibodies isolated from human survivors. Although the two antibodies studied blocked attachment to the host cell receptor, only the anti-SARS-CoV S antibody triggered fusogenic conformational changes via receptor functional mimicry. These results provide a structural framework for understanding coronavirus neutralization by human antibodies and shed light on activation of coronavirus membrane fusion, which takes place through a receptor-driven ratcheting mechanism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2018.12.028

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 46,047
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
XDS
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Punjani, A., Rubinstein, J. L., Fleet, D. J., & Brubaker, M. A. (2017) · Nature Methods · doi:10.1038/nmeth.4169 · Cited by 11,626
Inference of Macromolecular Assemblies from Crystalline State
Krissinel, E., & Henrick, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.022 · Cited by 10,007
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E. J., Armache, J., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,496
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkòczi, G., Chen, V. B., Davis, I., Echols, N., Headd, J. J., Hung, L., Kapral, G. J., Grosse‐Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923

Flagged first, then by citations

Show all 85 references

Sorted by citations

Items 201–300 of 587

Isolation of a human monoclonal antibody specific for the receptor binding domain of SARS-CoV-2 using a competitive phage biopanning strategy
Zeng, X. W., Li, L., Lin, J., Li, X., Liu, B., Kong, Y., Zeng, S., Du, J., Xiao, H., Zhang, T., et al. (2020) · Antibody Therapeutics · doi:10.1093/abt/tbaa008 · Cited by 53
In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform
Russo, G. L., Pennisi, M. A., Fichera, E., Motta, S., Raciti, G., Viceconti, M., & Pappalardo, F. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03872-0 · Cited by 56
Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
Wang, L., & Xiang, Y. (2020) · Viruses · doi:10.3390/v12111289 · Cited by 51
Glycans on the SARS-CoV-2 Spike Control the Receptor Binding Domain ConformationPreprint
Henderson, R. C., Edwards, R. J., Mansouri, K., Janowska, K., Stalls, V., Kopp, M., Haynes, B. F., & Acharya, P. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.26.173765 · Cited by 49
Minireview of progress in the structural study of SARS-CoV-2 proteins
Zhu, G., Zhu, C., Zhu, Y., & Sun, F. (2020) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2020.06.003 · Cited by 54
COVID-19 during Pregnancy and Postpartum:
Naidu, S. A. G., Clemens, R., Pressman, P., Zaigham, M., Kadkhoda, K., Davies, K. J. A., & Naidu, A. S. (2020) · Journal of Dietary Supplements · doi:10.1080/19390211.2020.1834049 · Cited by 57
Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry
Qing, E., Li, P., Cooper, L. M., Schulz, S. R., Jäck, H., Rong, L., Perlman, S. M., & Gallagher, T. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110786 · Cited by 45
An approach towards development of monoclonal IgY antibodies against SARS CoV-2 spike protein (S) using phage display method: A review
Somasundaram, R., Choraria, A., & Antonysamy, M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106654 · Cited by 51
Biparatopic sybodies neutralize SARS‐CoV‐2 variants of concern and mitigate drug resistance
Walter, J. D., Hutter, C. A. J., Garaeva, A. A., Scherer, M., Zimmermann, I., Wyss, M., Rheinberger, J., Ruedin, Y., Earp, J. C., Egloff, P., et al. (2022) · EMBO Reports · doi:10.15252/embr.202154199 · Cited by 49
Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan – implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2Preprint
Liu, T., Wu, S., Tao, H., Zeng, G., Zhou, F., Guo, F., & Wang, X. (2020) · medRxiv · doi:10.1101/2020.06.13.20130252 · Cited by 51
Human coronavirus HKU1 recognition of the TMPRSS2 host receptor
McCallum, M., Park, Y., Stewart, C., Sprouse, K. R., Addetia, A., Brown, J. T., Tortorici, M. A., Gibson, C. A., Wong, E., Ieven, M. M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.006 · Cited by 51
Self-citation
Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens
Vashi, Y., Jagrit, V., & Kumar, S. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104382 · Cited by 48
COVID-19 Modeling: A Review
Cao, L., & Liu, Q. (2024) · ACM Computing Surveys · doi:10.1145/3686150 · Cited by 52
Endocytosis and Transcytosis of SARS-CoV-2 Across the Intestinal Epithelium and Other Tissue Barriers
Knyazev, E. N., Nersisyan, S. A., & Tonevitsky, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.636966 · Cited by 47
A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron
Maeda, R., Fujita, J., Konishi, Y., Kazuma, Y., Yamazaki, H., Anzai, I., Watanabe, T., Yamaguchi, K., Kasai, K., Nagata, K., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03630-3 · Cited by 47
Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses
Park, Y., Liu, C., Lee, J., Brown, J. T., Ma, C., Liu, P., Gen, R., Xiong, Q., Zepeda, S. K., Stewart, C., et al. (2025) · Cell · doi:10.1016/j.cell.2024.12.032 · Cited by 47
Self-citation
Enabling online determination of the size-dependent RNA content of lipid nanoparticle-based RNA formulations
Jia, X., Liu, Y., Wagner, A. M., Chen, M. M., Zhao, Y., Smith, K. J., Some, D., Abend, A. M., & Pennington, J. P. (2021) · Journal of Chromatography B · doi:10.1016/j.jchromb.2021.123015 · Cited by 45
Structure‐guided envelope trimer design in HIV‐1 vaccine development: a narrative review
Derking, R., & Sanders, R. W. (2021) · Journal of the International AIDS Society · doi:10.1002/jia2.25797 · Cited by 46
Application of Humanized Zebrafish Model in the Suppression of SARS-CoV-2 Spike Protein Induced Pathology by Tri-Herbal Medicine Coronil via Cytokine Modulation
Balkrishna, A., Solleti, S. K., Verma, S., & Varshney, A. (2020) · Molecules · doi:10.3390/molecules25215091 · Cited by 42
Cryo-EM analysis of the HCoV-229E spike glycoprotein reveals dynamic prefusion conformational changes
Song, X., Shi, Y., Ding, W., Niu, T., Sun, L., Tan, Y., Chen, Y., Shi, J., Xiong, Q., Huang, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20401-y · Cited by 42
Conformational flexibility and structural variability of SARS-CoV2 S protein
Pramanick, I., Sengupta, N., Mishra, S., Pandey, S., Girish, N., Das, A., & Dutta, S. (2021) · Structure · doi:10.1016/j.str.2021.04.006 · Cited by 43
Cryo-EM Structures Delineate a pH-Dependent Switch that Mediates Endosomal Positioning of SARS-CoV-2 Spike Receptor-Binding DomainsPreprint
Zhou, T., Tsybovsky, Y., Olia, A. S., Gorman, J., Rapp, M., Cerutti, G., Chuang, G., Katsamba, P. S., Nazzari, A. F., Sampson, J. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.04.187989 · Cited by 48
SARS-CoV-2 spike protein: flexibility as a new target for fighting infection
Pierri, C. L. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00369-3 · Cited by 42
Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review
Hanna, R., Dalvi, S., Sălăgean, T., Pop, I., Bordea, I. R., & Benedicenti, S. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s282213 · Cited by 42
Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries
Pan, Y., Du, J., Liu, J., Wu, H., Gui, F., Zhang, N., Deng, X., Song, G., Li, Y., Lu, J., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00295-w · Cited by 44
Spike protein binding prediction with neutralizing antibodies of SARS-CoV-2Preprint
Park, T., Lee, S.-Y., Kim, S., Kim, M. J., Kim, H. G., Jun, S., Kim, S. I., Kim, B., Park, E. C., & Park, D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.22.951178 · Cited by 42
Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective
Huang, Y., Sun, H., Yu, H. J., Li, S., Zheng, Q., & Xia, N. (2020) · Antibody Therapeutics · doi:10.1093/abt/tbaa028 · Cited by 40
Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review
Wyganowska‐Świątkowska, M., Nohawica, M., Grocholewicz, K., & Nowak, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134639 · Cited by 40
Primed for global coronavirus pandemic: Emerging research and clinical outcome
Ahamad, S., Branch, S., Harrelson, S., Hussain, M. K., Saquib, M., & Khan, S. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112862 · Cited by 39
Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses
Beaudoin, C. A., Jamasb, A. R., Alsulami, A. F., Copoiu, L., van Tonder, A. J., Hala, S. M., Bannerman, B. P., Thomas, S. E., Vedithi, S. C., Torres, P. H. M., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.06.041 · Cited by 36
Glycan shield of the ebolavirus envelope glycoprotein GP
Peng, W., Rayaprolu, V., Parvate, A. D., Pronker, M. F., Hui, S., Parekh, D. V., Shaffer, K. C. L., Yu, X., Saphire, E. O., & Snijder, J. (2022) · Communications Biology · doi:10.1038/s42003-022-03767-1 · Cited by 42
Self-citation
Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19
Yu, S., Wang, J., & Shen, H. (2020) · Annals of Palliative Medicine · doi:10.21037/apm.2020.03.27 · Cited by 38
Potent monoclonal antibody–mediated neutralization of a divergent Hendra virus variant
Wang, Z., Dang, H. V., Amaya, M., Xu, Y., Yin, R., Yan, L., Hickey, A. C., Annand, E. J., Horsburgh, B. A., Reid, P. A., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122769119 · Cited by 37
Self-citation
Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies
Huang, Q., Han, X., & Yan, J. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2125348 · Cited by 37
Circular RNA CircEZH2 Suppresses Transmissible Gastroenteritis Coronavirus-induced Opening of Mitochondrial Permeability Transition Pore via Targeting MiR-22 in IPEC-J2
Zhao, X., Ma, X., Guo, J., Mi, M., Wang, K., Zhang, C., Tang, X., Chang, L., Huang, Y., & Tong, D. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.36532 · Cited by 35
Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2
Konwarh, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01531 · Cited by 36
Review of COVID-19 Antibody Therapies
Chen, J., Gao, K., Wang, R., Nguyen, D. D., & Wei, G. (2020) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-062920-063711 · Cited by 37
Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein
Zhang, S., Go, E. P., Ding, H., Anang, S., Kappes, J. C., Desaire, H., & Sodroski, J. (2021) · Journal of Virology · doi:10.1128/jvi.01626-21 · Cited by 39
Cryo-EM structure of coronavirus-HKU1 haemagglutinin esterase reveals architectural changes arising from prolonged circulation in humans
Hurdiss, D. L., Drulyte, I., Lang, Y., Shamorkina, T. M., Pronker, M. F., van Kuppeveld, F. J. M., Snijder, J., & de Groot, R. J. (2020) · Nature Communications · doi:10.1038/s41467-020-18440-6 · Cited by 38
Self-citation
The Impact of COVID-19 Management Policies Tailored to Airborne SARS-CoV-2 Transmission: Policy Analysis
Telles, C. R., Roy, A., Ajmal, M. R., Mustafa, S. K., Ahmad, M. A., de la Serna, J. M., Frigo, E. P., & Rosales, M. H. (2021) · JMIR Public Health and Surveillance · doi:10.2196/20699 · Cited by 35
Catch Me if You Can: Superspreading of COVID-19
Lakdawala, S. S., & Menachery, V. D. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.05.002 · Cited by 33
SpySwitch enables pH- or heat-responsive capture and release for plug-and-display nanoassembly
Vester, S. K., Rahikainen, R., Anuar, I. N. A. K., Hills, R. A., Tan, T. K., & Howarth, M. R. (2022) · Nature Communications · doi:10.1038/s41467-022-31193-8 · Cited by 35
Broad receptor tropism and immunogenicity of a clade 3 sarbecovirus
Lee, J., Zepeda, S. K., Park, Y., Taylor, A. L., Quispe, J. D., Stewart, C., Leaf, E. M., Treichel, C., Corti, D., King, N. P., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.10.018 · Cited by 33
Self-citation
Trained immunity as a novel approach against COVID‐19 with a focus on Bacillus Calmette–Guérin vaccine: mechanisms, challenges and perspectives
Sohrabi, Y., dos Santos, J. C., Dorenkamp, M., Findeisen, H. M., Godfrey, R., Netea, M. G., & Joosten, L. A. B. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1228 · Cited by 34
Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike ProteinsPreprint
Zhang, Y., Zhao, W., Mao, Y., Chen, Y., Wang, S., Zhong, Y., Su, T., Gong, M., Du, D., Lu, X., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.28.013276 · Cited by 37
Forecasting the timeframe of 2019-nCoV and human cells interaction with reverse engineering
Sohail, A., & Nutini, A. (2020) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2020.04.002 · Cited by 33
Molecular Insights on the Possible Role of Annexin A2 in COVID-19 Pathogenesis and Post-Infection Complications
Patil, P., Shetty, P. K., Kuriakose, N., Gollapalli, P., Shetty, S., Bhandary, R. R., Vishwanatha, J. K., & Ghate, S. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011028 · Cited by 33
Cryo-electron Microscopy Structure of the Swine Acute Diarrhea Syndrome Coronavirus Spike Glycoprotein Provides Insights into Evolution of Unique Coronavirus Spike Proteins
Guan, H., Wang, Y., Perčulija, V., Saeed, A. F. U. H., Liu, Y., Li, J., Jan, S. S., Li, Y., Zhu, P., & Ouyang, S. (2020) · Journal of Virology · doi:10.1128/jvi.01301-20 · Cited by 34
2020 update on human coronaviruses: One health, one world
Zhao, X., Ding, Y., Du, J., & Fan, Y. (2020) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2020.100043 · Cited by 36
Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country
Requena, D., Médico, A., Chacón, R. D., Ramírez, M., & Marín-Sánchez, O. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02008 · Cited by 34
Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2
Zhu, L., Deng, Y., Zhang, R.-R., Cui, Z., Sun, C.-Y., Fan, C., Xing, X., Huang, W., Chen, Q., Zhang, N.-N., et al. (2020) · National Science Review · doi:10.1093/nsr/nwaa297 · Cited by 34
Human Milk Antibodies against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with a Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers
Demers‐Mathieu, V., DaPra, C., Mathijssen, G. B., Sela, D. A., Järvinen, K. M., Seppo, A., Fels, S., & Medo, E. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041749 · Cited by 32
Gastrointestinal implications in COVID-19
Dahiya, D. S., Kichloo, A., Albosta, M. S., Pagad, S., & Wani, F. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001559 · Cited by 34
Interference of Polydatin/Resveratrol in the ACE2:Spike Recognition during COVID-19 Infection. A Focus on Their Potential Mechanism of Action through Computational and Biochemical Assays
Perrella, F., Coppola, F., Petrone, A., Platella, C., Montesarchio, D., Stringaro, A., Ravagnan, G., Fuggetta, M. P., Rega, N., & Musumeci, D. (2021) · Biomolecules · doi:10.3390/biom11071048 · Cited by 32
Label-free methods for optical in vitro characterization of protein–protein interactions
Soltermann, F., Struwe, W. B., & Kukura, P. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp01072g · Cited by 32
Site-Specific Glycosylation Patterns of the SARS-CoV-2 Spike Protein Derived From Recombinant Protein and Viral WA1 and D614G Strains
Tian, Y., Parsons, L. M., Jankowska, E. A., & Cipollo, J. F. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.767448 · Cited by 29
Design of a multi-epitope-based peptide vaccine against the S and N proteins of SARS-COV-2 using immunoinformatics approach
Rouzbahani, A. K., Kheirandish, F., & Hosseini, S. Z. (2022) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-022-00224-w · Cited by 32
Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations
Cocherie, T., Zafilaza, K., Leducq, V., Marot, S., Cálvez, V., Marcelin, A., & Todesco, È. (2022) · Microorganisms · doi:10.3390/microorganisms11010030 · Cited by 33
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2Preprint
Custódio, T. F., Das, H., Sheward, D. J., Hanke, L., Pažický, S., Pieprzyk, J., Sorgenfrei, M., Schroer, M. A., Gruzinov, A. Y., Jeffries, C. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.23.165415 · Cited by 32
Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2
Verkhivker, G. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218268 · Cited by 29
Biochemical Analysis of Coronavirus Spike Glycoprotein Conformational Intermediates during Membrane Fusion
Kawase, M., Kataoka, M., Shirato, K., & Matsuyama, S. (2019) · Journal of Virology · doi:10.1128/jvi.00785-19 · Cited by 32
Highly potent anti-SARS-CoV-2 multivalent DARPin therapeutic candidatesPreprint
Walser, M., Rothenberger, S., Hurdiss, D. L., Schlegel, A., Calabro, V., Fontaine, S., Villemagne, D., Paladino, M., Hospodarsch, T., Neculcea, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.25.256339 · Cited by 30
Exploring the Regulatory Function of the N‐terminal Domain of SARS‐CoV‐2 Spike Protein through Molecular Dynamics Simulation
Li, Y., Wang, T., Zhang, J., Shao, B., Gong, H., Wang, Y., He, X., Liu, S., & Liu, T. (2021) · Advanced Theory and Simulations · doi:10.1002/adts.202100152 · Cited by 29
Single-dose replicating RNA vaccine induces neutralizing antibodies against SARS-CoV-2 in nonhuman primatesPreprint
Erasmus, J. H., Khandhar, A. P., Walls, A. C., Hemann, E. A., O’Connor, M. A., Murapa, P., Archer, J. F., Leventhal, S. S., Fuller, J., Lewis, T. B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.28.121640 · Cited by 30
Self-citation
Structure and design of Langya virus glycoprotein antigens
Wang, Z., McCallum, M., Yan, L., Gibson, C. A., Sharkey, W., Park, Y.-J., Dang, H. V., Amaya, M., Person, A., Broder, C. C., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2314990121 · Cited by 32
Self-citation
Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein
Wintjens, R. T., Bifani, A. M., & Bifani, P. J. (2020) · npj Vaccines · doi:10.1038/s41541-020-00237-9 · Cited by 29
Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell–cell fusion
Thakur, N., Conceicao, C., Isaacs, A., Human, S., Modhiran, N., McLean, R. K., Pedrera, M., Tan, T. K., Rijal, P., Townsend, A., et al. (2020) · Journal of General Virology · doi:10.1099/jgv.0.001506 · Cited by 25
SARS-CoV-2, Early Entry Events
CHAMBERS, J. K., Yu, J., Valdés, J. J., & Arulanandam, B. P. (2020) · Journal of Pathogens · doi:10.1155/2020/9238696 · Cited by 32
Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides
Freitas, F. C., Ferreira, P. H. B., Favaro, D. C., & de Oliveira, R. J. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01320 · Cited by 29
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction
Biagioli, M., Marchianò, S., Roselli, R., Giorgio, C. D., Bellini, R., Bordoni, M., Gidari, A., Sabbatini, S., Francisci, D., Fiorillo, B., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114564 · Cited by 29
Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor
Kim, Y. S., Chung, H., Noh, S. G., Lee, B., Chung, H. Y., & Choi, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168604 · Cited by 29
A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19)
Widyasari, K., & Kim, J. N. (2023) · Antibodies · doi:10.3390/antib12010005 · Cited by 29
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
Shen, J., Fan, J., Zhao, Y., Jiang, D., Niu, Z., Zhang, Z., & Cao, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1159326 · Cited by 38
Molecular Evolution of SARS-CoV-2 Structural Genes: Evidence of Positive Selection in Spike GlycoproteinPreprint
Zhan, X.-Y., Zhang, Y., Zhou, X., Huang, K., Qian, Y., Leng, Y., Yan, L., Huang, B., & He, Y. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.25.170688 · Cited by 29
Neutralizing Aptamers Block S/RBD‐ACE2 Interactions and Prevent Host Cell Infection
Liu, X., Wang, Y., Wu, J., Qi, J., Zeng, Z., Wan, Q., Chen, Z., Manandhar, P., Cavener, V. S., Boyle, N. R., et al. (2021) · Angewandte Chemie · doi:10.1002/ange.202100345 · Cited by 28
End-to-End Protein Normal Mode Frequency Predictions Using Language and Graph Models and Application to Sonification
Hu, Y., & Buehler, M. J. (2022) · ACS Nano · doi:10.1021/acsnano.2c07681 · Cited by 26
Spike glycoproteins: Their significance for corona viruses and receptor binding activities for pathogenesis and viral survival
Noman, A., Aqeel, M. A., Khalid, N., Hashem, M., Alamari, S., Zafar, S., Qasim, M. U., Irshad, M. S., & Qari, S. H. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104719 · Cited by 28
COVID‐19 und Immunregulation – von grundlegenden und translationalen Aspekten zu klinischen Implikationen
Schön, M. P., Berking, C., Biedermann, T., Buhl, T., Erpenbeck, L., Eyerich, K., Eyerich, S., Ghoreschi, K., Goebeler, M., Ludwig, R. J., et al. (2020) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14169_g · Cited by 28
Union is strength: antiviral and anti-inflammatory drugs for COVID-19
Naveja, J. J., Madariaga‐Mazón, A., Flores‐Murrieta, F. J., Granados‐Montiel, J., Maradiaga‐Ceceña, M. A., Duarte-Alaniz, V., Maldonado-Rodriguez, M., García-Morales, J., Senosiain, J. P., & Martínez‐Mayorga, K. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.018 · Cited by 29
Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein
Chen, Y., Wu, Y., Chen, S., Zhan, Q., Wu, D., Yang, C., He, X., Qiu, M., Zhang, N., Li, Z., et al. (2022) · Journal of Virology · doi:10.1128/jvi.01245-22 · Cited by 27
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo
Torchia, J. A., Tavares, A. H., Carstensen, L. S., Chen, D. W., Huang, J., Xiao, T., Mukherjee, S., Reeves, P. M., Tu, H., Sluder, A. E., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq6527 · Cited by 25
Cryo-EM Studies of Virus-Antibody Immune Complexes
Li, N., Li, Z., Fu, Y., & Cao, S. (2020) · Virologica Sinica · doi:10.1007/s12250-019-00190-5 · Cited by 27
Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation
El-hoshoudy, A. N. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.113968 · Cited by 26
An overview of the use of biomaterials, nanotechnology, and stem cells for detection and treatment of COVID-19: towards a framework to address future global pandemics
Ghaffari, M. S., Mollazadeh-Bajestani, M., Moztarzadeh, F., Uludağ, H., Hardy, J. G., & Mozafari, M. (2021) · Emergent Materials · doi:10.1007/s42247-020-00143-9 · Cited by 26
Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses
Bullen, G., Galson, J. D., Hall, G., Villar, P., Moreels, L., Ledsgaard, L., Mattiuzzo, G., Bentley, E. M., Masters, E. W., Tang, D. G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.678570 · Cited by 26
Membrane lectins enhance SARS-CoV-2 infection and influence the neutralizing activity of different classes of antibodiesPreprint
Lempp, F., Soriaga, L. B., Montiel-Ruiz, M., Benigni, F., Noack, J., Park, Y.-J., Bianchi, S., Walls, A., Bowen, J., Zhou, J.-Y., et al. (2021) · bioRxiv · doi:10.1101/2021.04.03.438258 · Cited by 22
Self-citation
How glycobiology can help us treat and beat the COVID-19 pandemic
Lardone, R. D., Garay, Y. C., Parodi, P., de la Fuente, S., Angeloni, G., Bravo, E. O., Schmider, A. K., & Irazoqui, F. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100375 · Cited by 25
Antibody-mediated immunity to SARS-CoV-2 spike
Errico, J. M., Adams, L. J., & Fremont, D. H. (2022) · Advances in immunology · doi:10.1016/bs.ai.2022.07.001 · Cited by 22
The PRRA Insert at the S1/S2 Site Modulates Cellular Tropism of SARS-CoV-2 and ACE2 Usage by the Closely Related Bat RaTG13
Liu, S., Selvaraj, P., Lien, C. Z., Nuñez, I. A., Wu, W. W., Chou, C., & Wang, T. T. (2021) · Journal of Virology · doi:10.1128/jvi.01751-20 · Cited by 24
The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome‐Corona Virus‐2 (SARS‐CoV‐2)
Beeraka, N. M., Tulimilli, S. V., Karnik, M., Sadhu, S. P., Pragada, R. R., Aliev, G., & Madhunapantula, S. V. (2021) · BioMed Research International · doi:10.1155/2021/8160860 · Cited by 25
Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display
Tanaka, S., Olson, C. A., Barnes, C. O., Higashide, W., Gonzalez, M. R., Taft, J. D., Richardson, A., Martín-Fernández, M., Bogunovic, D., Gnanapragasam, P. N. P., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110348 · Cited by 20
A platform technology for generating subunit vaccines against diverse viral pathogens
Young, A., Isaacs, A., Scott, C. A. P., Modhiran, N., McMillan, C. L. D., Cheung, S. T. M., Barr, J. A., Marsh, G. A., Thakur, N., Bailey, D., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.963023 · Cited by 25
Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants
Yu, H., Liu, B., Zhang, Y., Gao, X., Wang, Q., Xiang, H., Peng, X., Xie, C., Wang, Y., Hu, P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36761-0 · Cited by 24
Self-citation
Coronavirus Spike (S) Protein: A Brief Review on Structure-Function Relationship, Host Receptors, and Role in Cell Infection
de Albuquerque, L. P., Patriota, L. L. D. S., Gonzatto, V., Pontual, E. V., Paiva, P. M. G., & Napoleão, T. H. (2020) · Advances in Research · doi:10.9734/air/2020/v21i930240 · Cited by 24
Modeling coronavirus spike protein dynamics: implications for immunogenicity and immune escape
Kunkel, G., Madani, M., White, S. J., Verardi, P. H., & Tarakanova, A. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.11.009 · Cited by 23
A SARS‐CoV‐2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD‐Independent Mechanism**
Schmitz, A., Weber, A., Bayin, M., Breuers, S., Fieberg, V., Famulok, M., & Mayer, G. (2021) · Angewandte Chemie · doi:10.1002/ange.202100316 · Cited by 24
Prefusion spike protein conformational changes are slower in SARS-CoV-2 than in SARS-CoV-1
Kumar, V. G., Ogden, D. S., Isu, U. H., Polasa, A., Losey, J., & Moradi, M. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101814 · Cited by 22
Advances in Targeting ACE2 for Developing COVID-19 Therapeutics
Suvarnapathaki, S., Chauhan, D., Nguyen, A., Ramalingam, M., & Camci‐Unal, G. (2022) · Annals of Biomedical Engineering · doi:10.1007/s10439-022-03094-w · Cited by 24
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike proteinPreprint
Wec, A. Z., Wrapp, D., Herbert, A. S., Maurer, D. P., Haslwanter, D., Sakharkar, M., Jangra, R. K., Dieterle, M. E., Lilov, A., Huang, D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.15.096511 · Cited by 23
A potent synthetic nanobody targets RBD and protects mice from SARS-CoV-2 infectionPreprint
Li, T., Cai, H., Yao, H., Zhou, B., Zhang, N., Gong, Y., Zhao, Y., Shen, Q., Qin, W., Hutter, C. A. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.09.143438 · Cited by 26

Authors: Walls, A. C., Xiong, X., Park, Y.-J., Tortorici, M. A., Snijder, J., Quispe, J., Cameroni, E., Gopal, R., Dai, M., Lanzavecchia, A., Zambon, M., Rey, F. A., Corti, D., & Veesler, D.
Affiliations: University of Washington (US)
Centre National de la Recherche Scientifique (FR)
Vir Biotechnology (Switzerland) (CH)
Public Health England (GB)
The Francis Crick Institute (GB)
Institute for Research in Biomedicine (CH)
Corresponding author: Veesler, David
ORCID: Walls, Alexandra C.
Xiong, Xiaoli
Park, Young-Jun
Tortorici, M. Alejandra
Snijder, Joost
Quispe, Joel
Cameroni, Elisabetta
Lanzavecchia, Antonio
Zambon, Maria
Corti, Davide
Veesler, David
Venue: Cell
Publisher: Elsevier BV
Published: 2019-02
Volume: 176
Issue: 5
Pages: 1026-1039.e15
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2018.12.028
PMC: PMC6751136
OpenAlex: W2915009278
Cited by: 582
References: 85
Citations by year: 2026: 7 · 2025: 25 · 2024: 30 · 2023: 40 · 2022: 79 · 2021: 173 · 2020: 214 · 2019: 14
FWCI: 92.33
Type: journal article
Language: en
Update notices: erratum (2020-12-10)
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 385 d)
Locations: Cell (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
Funders: National Institute of General Medical Sciences (R01GM120553)
National Institute of Allergy and Infectious Diseases (HHSN272201700059C)
Pew Biomedical Scholars Award
Burroughs Wellcome Fund
Netherlands Organisation for Scientific Research (Rubicon 019.2015.2.310.006)
European Molecular Biology Organization (ALTF933-2015)
Zoonoses Anticipation and Preparedness Initiative (IMI115760)
Pasteur Institute
Centre National de la Recherche Scientifique
LabEx Integrative Biology of Emerging Infectious Diseases
University of Washington Arnold and Mabel Beckman CryoEM Center and Proteomics Resource (UWPR95794)
Advanced Light Source at Lawrence Berkley National Laboratory
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords: SARS-CoV, MERS-CoV, neutralizing antibodies, antibody-antigen complex structure, humoral immune response, viral entry, receptor binding
MeSH terms: Animals, Antibodies, Monoclonal, Antibodies, Viral, Chlorocebus aethiops, Humans, Protein Binding, Receptors, Virus, Vero Cells, Coronavirus, Coronavirus Infections, Molecular Mimicry, Severe acute respiratory syndrome-related coronavirus, Virus Internalization, Immunity, Humoral, Antibodies, Neutralizing, HEK293 Cells, Spike Glycoprotein, Coronavirus, Middle East Respiratory Syndrome Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks